Loading...

Robert Judson-Torres, PhD

Title(s)Assistant Researcher, Dermatology
SchoolSchool of Medicine
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Wesleyan UniversityBA2005Molecular Biology & Biochemistry
    University of California, San FranciscoPh.D.2012Biomedical Sciences

    Collapse Research 
    Collapse Research Activities and Funding
    MicroRNA-Based Detection of Barriers to Melanoma Progression
    NIH DP5OD019787Sep 12, 2014 - Aug 31, 2019
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Websites
    Collapse In The News

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Zhang Y, Judson RL. Evaluation of holographic imaging cytometer holomonitor M4® motility applications. Cytometry A. 2018 Nov; 93(11):1125-1131. PMID: 30343513.
      View in: PubMed
    2. Zeng H, Jorapur A, Shain AH, Lang UE, Torres R, Zhang Y, McNeal AS, Botton T, Lin J, Donne M, Bastian IN, Yu R, North JP, Pincus L, Ruben BS, Joseph NM, Yeh I, Bastian BC, Judson RL. Bi-allelic Loss of CDKN2A Initiates Melanoma Invasion via BRN2 Activation. Cancer Cell. 2018 Jul 09; 34(1):56-68.e9. PMID: 29990501.
      View in: PubMed
    3. Shain AH, Joseph NM, Yu R, Benhamida J, Liu S, Prow T, Ruben B, North J, Pincus L, Yeh I, Judson R, Bastian BC. Genomic and Transcriptomic Analysis Reveals Incremental Disruption of Key Signaling Pathways during Melanoma Evolution. Cancer Cell. 2018 Jul 09; 34(1):45-55.e4. PMID: 29990500.
      View in: PubMed
    4. Yeh I, Lang UE, Durieux E, Tee MK, Jorapur A, Shain AH, Haddad V, Pissaloux D, Chen X, Cerroni L, Judson RL, LeBoit PE, McCalmont TH, Bastian BC, de la Fouchardière A. Combined activation of MAP kinase pathway and ß-catenin signaling cause deep penetrating nevi. Nat Commun. 2017 09 21; 8(1):644. PMID: 28935960.
      View in: PubMed
    5. Hejna M, Jorapur A, Song JS, Judson RL. High accuracy label-free classification of single-cell kinetic states from holographic cytometry of human melanoma cells. Sci Rep. 2017 Sep 20; 7(1):11943. PMID: 28931937.
      View in: PubMed
    6. Huskey NE, Guo T, Evason KJ, Momcilovic O, Pardo D, Creasman KJ, Judson RL, Blelloch R, Oakes SA, Hebrok M, Goga A. CDK1 inhibition targets the p53-NOXA-MCL1 axis, selectively kills embryonic stem cells, and prevents teratoma formation. Stem Cell Reports. 2015 Mar 10; 4(3):374-89. PMID: 25733019; PMCID: PMC4375943.
    7. Parchem RJ, Ye J, Judson RL, LaRussa MF, Krishnakumar R, Blelloch A, Oldham MC, Blelloch R. Two miRNA clusters reveal alternative paths in late-stage reprogramming. Cell Stem Cell. 2014 May 01; 14(5):617-31. PMID: 24630794; PMCID: PMC4305531.
    8. Judson RL, Greve TS, Parchem RJ, Blelloch R. MicroRNA-based discovery of barriers to dedifferentiation of fibroblasts to pluripotent stem cells. Nat Struct Mol Biol. 2013 Oct; 20(10):1227-35. PMID: 24037508; PMCID: PMC3955211.
    9. Greve TS, Judson RL, Blelloch R. microRNA control of mouse and human pluripotent stem cell behavior. Annu Rev Cell Dev Biol. 2013; 29:213-239. PMID: 23875649; PMCID: PMC4793955.
    10. Subramanyam D, Lamouille S, Judson RL, Liu JY, Bucay N, Derynck R, Blelloch R. Multiple targets of miR-302 and miR-372 promote reprogramming of human fibroblasts to induced pluripotent stem cells. Nat Biotechnol. 2011 May; 29(5):443-8. PMID: 21490602; PMCID: PMC3685579.
    11. Swarbrick A, Woods SL, Shaw A, Balakrishnan A, Phua Y, Nguyen A, Chanthery Y, Lim L, Ashton LJ, Judson RL, Huskey N, Blelloch R, Haber M, Norris MD, Lengyel P, Hackett CS, Preiss T, Chetcuti A, Sullivan CS, Marcusson EG, Weiss W, L'Etoile N, Goga A. miR-380-5p represses p53 to control cellular survival and is associated with poor outcome in MYCN-amplified neuroblastoma. Nat Med. 2010 Oct; 16(10):1134-40. PMID: 20871609; PMCID: PMC3019350.
    12. Melton C, Judson RL, Blelloch R. Opposing microRNA families regulate self-renewal in mouse embryonic stem cells. Nature. 2010 Feb 04; 463(7281):621-6. PMID: 20054295; PMCID: PMC2894702.
    13. Judson RL, Babiarz JE, Venere M, Blelloch R. Embryonic stem cell-specific microRNAs promote induced pluripotency. Nat Biotechnol. 2009 May; 27(5):459-61. PMID: 19363475; PMCID: PMC2743930.
    14. Ebina H, Chatterjee AG, Judson RL, Levin HL. The GP(Y/F) domain of TF1 integrase multimerizes when present in a fragment, and substitutions in this domain reduce enzymatic activity of the full-length protein. J Biol Chem. 2008 Jun 06; 283(23):15965-74. PMID: 18397885; PMCID: PMC2414268.
    15. Atwood-Moore A, Yan K, Judson RL, Levin HL. The self primer of the long terminal repeat retrotransposon Tf1 is not removed during reverse transcription. J Virol. 2006 Aug; 80(16):8267-70. PMID: 16873283; PMCID: PMC1563812.